Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultrapharm is a specialist healthcare nutrition company focused on the development and manufacture of gluten-free bakery products for patients with celiac disease and other gluten-related disorders. Established in 1993, the company has built a reputation for high-quality medical food products, operating production sites in the United Kingdom and Poland. Its portfolio includes a variety of specialized breads and baked goods designed to meet the strict dietary requirements of the gluten-free community and healthcare providers. In 2018, Ultrapharm was acquired by Dr. Schär, the European market leader in gluten-free nutrition, to strengthen its manufacturing capabilities and distribution network. The company continues to operate as a key production hub within the Dr. Schär group, serving both retail and clinical prescription markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ultrapharm.